Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes

Clinical Endocrinology

Volumn 65, Issue 1, 2006, Pages 35-39

  Dorkhan, Mozhgan ^a   Lantz, Mikael ^a   Frid, Anders ^a   Groop, Leif ^a   Hallengren, Bengt ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; HEMOGLOBIN A1C; LEVOTHYROXINE; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; FEMALE; HUMAN; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; THYROID DISEASE;

ADIPONECTIN; AGED; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EXOPHTHALMOS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; METFORMIN; MIDDLE AGED; PROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES;

EID: 33745192492     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02542.x     Document Type: Article

References (24)

1. Nolan J.J. Ludvik B. Beerdsen P. Joyce M. Olefsky J. ( 1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. New England Journal of Medicine, 331, 1188 1193.
2. Lehmann J.M. Moore L.B. Smith-Oliver T.A. Wilkison W.O. Willson T.M. Kliewer S.A. ( 1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). Journal of Biological Chemistry, 270, 12953 12956.
3. Saltiel A.R. Olefsky J.M. ( 1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes, 45, 1661 1669.
4. Mori Y. Murakawa Y. Okada K. Horikoshi H. Yokoyama J. Tajima N. Ikeda Y. ( 1999) Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care, 22, 908 912.
5. Adams M. Montague C.T. Prins J.B. Holder J.C. Smith S.A. Sanders L. Digby J.E. Sewter C.P. Lazar M.A. Chatterjee V.K. O'Rahilly S. ( 1997) Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. Journal of Clinical Investigations, 100, 3149 3153.
6. Starkey K. Heufelder A. Baker G. Joba W. Evans M. Davies S. Ludgate M. ( 2003) Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use? Journal of Clinical Endocrinology and Metabolism, 88, 55 59.
7. Mourits M.P. Koornneef L. Wiersinga W.M. Prummel M.F. Berghout A. van der Gaag R. ( 1989) Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. British Journal of Ophthalmology, 73, 639 644.
8. Bartalena L. Pinchera A. Marcocci C. ( 2000) Management of Graves' ophthalmopathy: reality and perspectives. Endocrine Reviews, 21, 168 199.
9. Asman P. ( 2003) Ophthalmological evaluation in thyroid-associated ophthalmopathy. Acta Ophthalmologica Scandinavica, 81, 437 448.
10. Levin F. Kazim M. Smith T.J. Marcovici E. ( 2005) Rosiglitazone-induced proptosis. Archives of Ophthalmology, 123, 119 121.
11. Yaturu S. Prado S. Grimes S.R. ( 2004) Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. Journal of Cell Biochemistry, 93, 491 496.
12. Kumar S. Coenen M.J. Scherer P.E. Bahn R.S. ( 2004) Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 89, 930 935.
13. Valyasevi R.W. Harteneck D.A. Dutton C.M. Bahn R.S. ( 2002) Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. Journal of Clinical Endocrinology and Metabolism, 87, 2352 2358.
14. Smith T.J. Koumas L. Gagnon A. Bell A. Sempowski G.D. Phipps R.P. Sorisky A. ( 2002) Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 87, 385 392.
15. Shen D.C. Davidson M.B. ( 1985) Hyperthyroid Graves' disease causes insulin antagonism. Journal of Clinical Endocrinology and Metabolism, 60, 1038 1041.
16. Ahren B. Lundquist I. Hedner P. Valdemarsson S. Schersten B. ( 1985) Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment. Diabetes Research, 2, 95 103.
17. Iglesias P. Alvarez Fidalgo P. Codoceo R. Diez J.J. ( 2003) Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clinical Endocrinology, 59, 621 629.
18. Santini F. Marsili A. Mammoli C. Valeriano R. Scartabelli G. Pelosini C. Giannetti M. Centoni R. Vitti P. Pinchera A. ( 2004) Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. Journal of Endocrinological Investigation, 27, RC5 7.
19. Lantz M. Vondrichova T. Parikh H. Frenander C. Ridderstrale M. Asman P. Aberg M. Groop L. Hallengren B. ( 2005) Overexpression of immediate early genes in active Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 90, 4784 4791.
20. Kumar S. Leontovich A. Coenen M.J. Bahn R.S. ( 2005) Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis. Journal of Clinical Endocrinology and Metabolism, 90, 4730 4735.
21. Shine B. Fells P. Edwards O.M. Weetman A.P. ( 1990) Association between Graves' ophthalmopathy and smoking. Lancet, 335, 1261 1263.
22. Hegedius L. Brix T.H. Vestergaard P. ( 2004) Relationship between cigarette smoking and Graves' ophthalmopathy. Journal of Endocrinological Investigation, 27, 265 271.
23. Hagg E. Asplund K. ( 1987) Is endocrine ophthalmopathy related to smoking? British Medical Journal (Clinical research ed.), 295, 634 635.
24. Weyer C. Funahashi T. Tanaka S. Hotta K. Matsuzawa Y. Pratley R.E. Tataranni P.A. ( 2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism, 86, 1930 1935.